Castle Biosciences snaps up San Diego’s AltheaDx to push precision medicine into mental health

Houston-based company will pay $65 million in cash and stock for AltheaDx, which makes a pharmacogenomics tests to guide clinicians on drug therapies for depression and anxiety.

Click here to view original post